These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10320836)

  • 1. Renal disease and the heart.
    Woolfson RG
    Hosp Med; 1999 Feb; 60(2):85-9. PubMed ID: 10320836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart valve calcifications, survival, and cardiovascular risk in hemodialysis patients.
    Panuccio V; Tripepi R; Tripepi G; Mallamaci F; Benedetto FA; Cataliotti A; Bellanuova I; Giacone G; Malatino LS; Zoccali C
    Am J Kidney Dis; 2004 Mar; 43(3):479-84. PubMed ID: 14981606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased prevalence of coronary artery disease, silent myocardial ischemia, complex ventricular arrhythmias, atrial fibrillation, left ventricular hypertrophy, mitral annular calcium, and aortic valve calcium in patients with chronic renal insufficiency.
    Das M; Aronow WS; McClung JA; Belkin RN
    Cardiol Rev; 2006; 14(1):14-7. PubMed ID: 16371761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential management of cardiovascular disease in ESRD by nephrologists and cardiologists.
    Martirosyan HA; Brass EP; Mehrotra R; Adler SG;
    Am J Kidney Dis; 2004 Aug; 44(2):309-21. PubMed ID: 15264190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensive Hemodialysis, Left Ventricular Hypertrophy, and Cardiovascular Disease.
    McCullough PA; Chan CT; Weinhandl ED; Burkart JM; Bakris GL
    Am J Kidney Dis; 2016 Nov; 68(5S1):S5-S14. PubMed ID: 27772643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of hypertension in renal failure patients: when do we overtreat? When do we undertreat?
    Rosansky SJ
    Blood Purif; 1996; 14(4):315-20. PubMed ID: 8873957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular hypertrophy is a risk factor independent of hypertension in survival of hemodialyzed patients.
    Nakamura S; Sasaki O; Nakahama H; Inenaga T; Kimura G
    Ren Fail; 2002 Mar; 24(2):175-86. PubMed ID: 12071591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common medical conditions in elderly dental patients. Part one: cardiovascular implications and management.
    Grover S; Rhodus NL
    Northwest Dent; 2012; 91(5):29-35. PubMed ID: 23155840
    [No Abstract]   [Full Text] [Related]  

  • 9. Difficult cardiac situations in renal transplant patients.
    Paydas S; Acarturk E
    Adv Ther; 2005; 22(1):19-24. PubMed ID: 15943218
    [No Abstract]   [Full Text] [Related]  

  • 10. Left ventricular hypertrophy, ischemic heart disease and the incidence of cardiovascular events in Japanese high-risk hypertensive patients.
    Seto S
    Circ J; 2009 Jun; 73(6):1014-5. PubMed ID: 19465782
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiac pathology in patients with end-stage renal disease maintained on hemodialysis.
    Ansari A; Kaupke CJ; Vaziri ND; Miller R; Barbari A
    Int J Artif Organs; 1993 Jan; 16(1):31-6. PubMed ID: 8458668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Options in dialysis therapy: significance of cardiovascular findings.
    Wizemann V; Timio M; Alpert MA; Kramer W
    Kidney Int Suppl; 1993 Feb; 40():S85-91. PubMed ID: 8445844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interplay of volume, blood pressure, organ ischemia, residual renal function, and diet: certainties and uncertainties with dialytic management.
    Ok E; Levin NW; Asci G; Chazot C; Toz H; Ozkahya M
    Semin Dial; 2017 Sep; 30(5):420-429. PubMed ID: 28581677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiovascular diseases in patients with chronic renal diseases].
    Dimković N
    Srp Arh Celok Lek; 2008 May; 136 Suppl 2():135-41. PubMed ID: 18924484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The treatment of ischemic heart disease in patients with chronic kidney failure].
    Diadyk AI; Bagriĭ AE; Stulikova EL
    Lik Sprava; 1998 Jun; (4):42-5. PubMed ID: 9784699
    [No Abstract]   [Full Text] [Related]  

  • 16. ACE inhibitors captopril and enalapril induce regression of left ventricular hypertrophy in hypertensive patients with chronic renal failure.
    Dyadyk AI; Bagriy AE; Lebed IA; Yarovaya NF; Schukina EV; Taradin GG
    Nephrol Dial Transplant; 1997 May; 12(5):945-51. PubMed ID: 9175047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardiovascular abnormalities in patients with obstructive sleep apnoea syndrome].
    Myśliński W; Dybała A; Mosiewicz J; Prystupa A; Hanzlik J
    Wiad Lek; 2005; 58(1-2):78-83. PubMed ID: 15991558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology of left ventricular hypertrophy in dialysis patients.
    London GM; Guerin AP; Marchais SJ
    Blood Purif; 1994; 12(4-5):277-83. PubMed ID: 7865187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of hypertension on cardiovascular outcomes in hemodialysis patients.
    Birchem JA; Fraley MA; Senkottaiyan N; Alpert MA
    Semin Dial; 2005; 18(5):391-5. PubMed ID: 16191179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morbidity and mortality due to hypertension in patients with renal failure.
    Ritz E; Koch M
    Am J Kidney Dis; 1993 May; 21(5 Suppl 2):113-8. PubMed ID: 8494009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.